Control of gammaherpesvirus latency by latent antigen-specific CD8+ T cells

Journal of Experimental Medicine

Volumn 192, Issue 7, 2000, Pages 943-952

  Usherwood, Edward J ^a   Roy, Douglas J ^b   Ward, Kim ^a   Surman, Sherri L ^c   Dutia, Bernadette M ^b   Blackman, Marcia A ^a   Stewart, James P ^b   Woodland, David L ^a  

^a TRUDEAU INSTITUTE   (United States)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

CD8+ T lymphocytes; Gammaherpesvirus; Viral antigens; Viral load; Virus latency

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL KINETICS; CELLULAR IMMUNITY; GENE EXPRESSION; HERPES; HERPES VIRUS; IMMUNE RESPONSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; VACCINATION; VIRUS LATENCY; VIRUS LOAD;

ANIMALS; ANTIGENS, VIRAL; B-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; EPITOPES, T-LYMPHOCYTE; GAMMAHERPESVIRINAE; GENE EXPRESSION PROFILING; GENES, VIRAL; H-2 ANTIGENS; HUMANS; IMMUNOLOGIC MEMORY; KINETICS; MICE; MICE, INBRED BALB C; TUMOR CELLS, CULTURED; VIRUS LATENCY;

EID: 0034596818     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.192.7.943     Document Type: Article

References (34)

1. Identification of human herpesvirus 8-specific cytotoxic T-cell responses
2. Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection
3. + T cells during the primary immune response to Epstein-Barr virus in vivo
4. Virological and pathological features of mice infected with murine gamma-herpesvirus 68
5. Macrophages are the major reservoir of latent murine gammaherpesvirus 68 in peritoneal cells
6. B cells regulate murine gammaherpesvirus 68 latency
7. Lung epithelial cells are a major site of murine gammaherpesvirus persistence
8. Latent murine gammaherpesvirus infection is established in activated B cells, dendritic cells, and macrophages
9. Lytic cycle T cell epitopes are expressed in two distinct phases during MHV-68 infection
10. + T lymphocytes
11. Three distinct regions of the murine gammaherpesvirus 68 genome are transcriptionally active in latently infected mice
12. Analysis of murine gammaherpesvirus-68 transcription during lytic and latent infection
13. Characterization of tumor cell lines derived from murine gammaherpesvirus-68-infected mice
14. Allogeneic H-2 antigen expression is insufficient for tumor rejection
15. + T cells
16. Counting antigen-specific CD8 T cells: A reevaluation of bystander activation during viral infection
17. Antigen-inducible, H-2-restricted, interleukin-2-producing T cell hybridomas. Lack of independent antigen and H-2 recognition
18. Phenotypic analysis of antigen-specific T lymphocytes
19. + T cell-mediated spontaneous diabetes in neonatal mice
20. Genetic content and preliminary transcriptional analysis of a representative region of murine gammaherpesvirus 68
21. Rta of murine gammaherpesvirus 68 reactivates the complete lytic cycle from latency
22. + T cells in vivo during latent murine gammaherpesvirus infection
23. Pathogenesis of an infectious mononucleosis-like disease induced by a murine gamma-herpesvirus: Role for a viral superantigen?
24. Absence of splenic latency in murine gammaherpesvirus 68-infected B cell-deficient mice
25. Murine gammaherpesvirus 68 establishes a latent infection in mouse B lymphocytes in vivo
26. Mature B cells are required for acute splenic infection, but not for establishment of latency, by murine gammaherpesvirus 68
27. + T cell response during acute and persistent murine gamma-herpesvirus infection
28. EBV structural antigens, gp350 and gp85, as targets for ex vivo virus-specific CTL during acute infectious mononucleosis: Potential use of gp350/gp85 CTL epitopes for vaccine design
29. T-cell vaccination alters the course of murine herpesvirus 68 infection and the establishment of viral latency in mice
30. + T cell response primed to a lyric-phase epitope
31. Strategies involved in developing an effective vaccine for EBV-associated diseases
32. Direct correlation between the load of Epstein-Barr virus-infected lymphocytes in the peripheral blood of pediatric transplant patients and risk of lymphoproliferative disease
33. Increased levels of circulating Epstein-Barr virus (EBV)-infected lymphocytes and decreased EBV nuclear antigen antibody responses are associated with the development of posttransplant lymphoproliferative disease in solid-organ transplant recipients
34. Complete sequence and genomic analysis of murine gammaherpesvirus 68